|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"kao jh"
Showing items 1-50 of 161 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-12-16 |
Telemedicine facilitates medical care for hospitalized patients in quarantine
|
Su, TH;Lu, YC;Li, JW;Liu, WD;Lee, MS;Hung, CS;Chou, CF;Wang, JT;Ho, YL;Kao, JH |
| 國家衛生研究院 |
2023-03 |
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes
|
Yu, ML;Wang, CY;Lee, MH;Ou, HY;Cheng, PN;Tu, ST;Huang, JF;Chen, JF;Hu, TH;Hsu, CC;Kao, JH;Chen, CJ;Lin, HC;Huang, CN |
| 臺大學術典藏 |
2022-02-09T07:39:02Z |
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|
Kao, JH; Huang, HT; KO-JEN LI |
| 中山醫學大學 |
2021 |
EIGHT-YEAR ENTECAVIR THERAPY CONTINUOUSLY REDUCES LIVER ADVERSE EVENTS IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS
|
Su, TH; Hu, TH; Chuang, WL; Su, WW; Lin, CC; Peng, CY; Wang, CC; Hsu, YC; Huang, YW; Tseng, KC; Lin, CL; Yang, SS; Suk, FM; Hsu, SJ; Chen, TM; Bair, MJ; Lin, CK; Hsieh, TY; Wang, HY; Tseng, TC; Kao, JH |
| 中山醫學大學 |
2021 |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu, CH; Peng, CY; Kao, WY; Yang, SS; Shih, YL; Lin, CL; Tsai, MK; Lee, CY; Chang, CC; Wu, JH; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
|
Liu, CH; Chen, CY; Su, WW; Liu, CJ; Lo, CC; Huang, KJ; Chen, JJ; Tseng, KC; Chang, CY; Peng, CY; Shih, YL; Huang, CS; Kao, WY; Yang, SS; Tsai, MC; Wu, JH; Chen, PY; Su, PY; Hwang, JJ; Fang, YJ; Lee, PL; Tseng, CW; Lee, FJ; Lai, HC; Hsieh, TY; Chang, CC; Chang, CH; Huang, YJ; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu, CH; Chen, PY; Chen, JJ; Lo, CC; Su, WW; Tseng, KC; Liu, CJ; Huang, CS; Huang, KJ; Yang, SS; Peng, CY; Tsai, MC; Kao, WY; Chang, CY; Shih, YL; Fang, YJ; Chen, CY; Lee, PL; Huang, JJ; Su, PY; Tseng, CW; Hung, CC; Chang, CH; Huang, YJ; Lai, HC; Chang, CC; Lee, FJ; Hsieh, TY; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Chen, CY; Su, WW; Tseng, KC; Lo, CC; Liu, CJ; Chen, JJ; Peng, CY; Shih, YL; Yang, SS; Huang, CS; Huang, KJ; Chang, CY; Tsai, MC; Kao, WY; Fang, YJ; Chen, PY; Su, PY; Tseng, CW; Huang, JJ; Lee, PL; Lai, HC; Hsieh, TY; Chang, CH; Huang, YJ; Lee, FJ; Chang, CC; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 國家衛生研究院 |
2020-04-10 |
Hepatitis C virus genotypes 1–3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes
|
Hsu, CS;Liu, WL;Li, Q;Lowey, B;Hertz, L;Chao, YC;Liang, TJ;Chen, DS;Kao, JH |
| 中山醫學大學 |
2020 |
IMPACT OF SOFOSBUVIR-BASED VERSUS NON-SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS ON RENAL FUNCTION IN CHRONIC HEPATITIS C PATIENTS WITH IMPAIRED RENAL FUNCTION- A LARGE COHORT STUDY FROM THE NATIONWIDE REAL-WORLD HCV REGISTRY PROGRAM (TACR)
|
Yu, ML; Chen, CY; Yi, C; Cheng, PN; Tseng, KC; Lo, CC; Hung, CH; Lin, CY; Chen, CH; Peng, CY; Bair, MJ; Hsieh, TY; Lee, PL; Yang, CC; Lin, CL; Mo, LR; Su, WW; Tsai, WL; Chang, CC; Lin, CC; Hsu, SJ; Liu, CH; Huang, YH; Hu, CT; Liu, CJ; Kao, JH; Lee, MH; Chien, RN; Dai, CY; Tsai, PC |
| 中山醫學大學 |
2020 |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Yang, SS; Peng, CY; Lin, WT; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang, WY; Chiu, YC; Chiu, FW; Hsu, YC; Tseng, TC; Cheng, PN; Yang, SS; Liu, CJ; Su, TH; Yang, HC; Liu, CH; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
|
Hsu, SJ; Yang, SS; Kao, JH |
| 中山醫學大學 |
2020 |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu, CH; Peng, CY; Fang, YJ; Kao, WY; Yang, SS; Lin, CK; Lai, HC; Su, WP; Fang, SU; Chang, CC; Su, TH; Liu, CJ; Chen, PJ; Chen, DS; Kao, JH |
| 國立交通大學 |
2019-04-02T05:59:51Z |
Ultrathin N2O-oxide with atomically flat interfaces
|
Chin, A; Chen, WJ; Lin, BC; Kao, JH; Tsai, C; Huang, JCM |
| 國家衛生研究院 |
2018-12 |
A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment
|
Liu, YT;Tseng, TC;Soong, RS;Peng, CY;Cheng, YH;Huang, SF;Chuang, TH;Kao, JH;Huang, LR |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B
|
Lin, C.-L.;Kao, J.-H.; Lin, CL; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Diagnosis of hepatitis B virus infection through serological and virological markers
|
Kao, J.-H.; JIA-HORNG KAO; Kao, JH |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:21Z |
Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; Tseng, TC; CHUN-JEN LIU; Liu, CJ; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:33:20Z |
Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma
|
Lin, C.-L.;Kao, J.-H.; Yang, Chun-Ming; JIA-HORNG KAO; Lin, CL; Kao, JH.; Lin, Gong-Hong; Chen, Mei-Hsiang; Hsueh, I-Ping; Hsieh, Ching-Lin |
| 臺大學術典藏 |
2018-09-10T06:33:18Z |
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients
|
Wang, C.-C.;Liu, C.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lai, My; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users
|
PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; Lai, MY; JIA-HORNG KAO; Chen, DS; Kao, JH.; Lin, C.-.;Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; Lin, CL; Liu, CJ |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan
|
Tseng, T.-C.; Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Lin, C.-L.; Kao, J.-K.; Chen, D.-S.; CHUN-JEN LIU; Tseng, TC; Liu, CJ; PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; JIA-HORNG KAO; Lai, MY; Lin, CL; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Shao, Yu-Yun; Liu, CJ; PEI-JER CHEN; Lai, MY; DING-SHINN CHEN; Lee, Yi-Hsuan; Hsieh, Min-Shu; JIA-HORNG KAO; Chen, PJ; Kao, JH; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Chen, DS.; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒; Hsu, CS; Hsu, C.-S.; Liu, C.-J.; Lai, M.-Y.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; Lu, Li-Chun; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
|
Lin, Chih-Lin; Liao, Li-Ying; Liu, Chun-Jen; Yu, Ming-Whei; Chen, Pei-Jer; Lai, Ming-Yang; Chen, Ding-Shinn; Kao, Jia-Horng; Lin, Chih-Lin; MING-WHEI YU; Lin, CL; Liao, LY; Liao, Li-Ying; CHUN-JEN LIU; Liu, CJ; PEI-JER CHEN; Liu, Chun-Jen; Kao, Jia-Horng; Kao, JH.; Chen, Ding-Shinn; Chen, DS; Lai, Ming-Yang; Lai, MY; Chen, Pei-Jer; Chen, PJ; JIA-HORNG KAO; DING-SHINN CHEN; Yu, MW; Yu, Ming-Whei |
| 臺大學術典藏 |
2018-09-10T06:33:01Z |
Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma
|
Lin, C.-L.; Liu, C.-H.; Chen, W.; Huang, W.-L.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; Lin, CL; PEI-JER CHEN; CHEN-HUA LIU; Liu, CH; DING-SHINN CHEN; Chen, W; JIA-HORNG KAO; Huang, WL; Chen, PJ; Lai, MY; Chen, DS; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:29:35Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng, WH;Kao, JH;Chen, PJ;Huang, LM;Chang, SY;Sun, HY;Hung, CC;Chen, MY;Chang, SC.; Sheng, W.-H. and Kao, J.-H. and Chen, P.-J. and Huang, L.-M. and Chang, S.-Y. and Sun, H.-Y. and Hung, C.-C. and Chen, M.-Y. and Chang, S.-C.; Sheng, WH; SUI-YUAN CHANG; PEI-JER CHEN; Kao, JH; WANG-HUEI SHENG; Chen, PJ; SHAN-CHWEN CHANG; Huang, LM; HSIN-YUN SUN; Chang, SY; JIA-HORNG KAO; Sun, HY; Hung, CC; CHIEN-CHING HUNG; Chen, MY; Chang, SC. |
| 臺大學術典藏 |
2018-09-10T06:29:34Z |
Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study
|
Hung, CC; SZU-MIN HSIEH; Kao, JH; WANG-HUEI SHENG; Chang, SY; SHAN-CHWEN CHANG; Chen, MY; JIA-HORNG KAO; Hsieh, SM; Chen, PJ; CHIEN-CHING HUNG; Chang, SC.; Sheng, WH;Hung, CC;Kao, JH;Chang, SY;Chen, MY;Hsieh, SM;Chen, PJ;Chang, SC.; Sheng, W.-H. and Hung, C.-C. and Kao, J.-H. and Chang, S.-Y. and Chen, M.-Y. and Hsieh, S.-M. and Chen, P.-J. and Chang, S.-C.; Sheng, WH; SUI-YUAN CHANG; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T06:14:05Z |
Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index.
|
Hsu, SJ; CHUN-JEN LIU; Chang, Chi-Yang; Lin, JW; PEI-JER CHEN; CHEN-HUA LIU; Hwang, JJ; Liu, CJ; PEI-MING YANG; DING-SHINN CHEN; Yang, PM; Lai, MY; JIA-HORNG KAO; Chen, PJ; Chen, JH; Kao, JH; Chen, DS.; Liu, CH; JUEY-JEN HWANG; Chang, Chi-Yang;Kao, JH;Lai, MY;Chen, DS.;Yang, PM;Hwang, JJ;Lin, JW;Hsu, SJ;Liu, CJ;Liu, CH;Chen, JH;Chen, PJ;JUEY-JEN HWANG;CHUN-JEN LIU;PEI-JER CHEN;CHEN-HUA LIU;PEI-MING YANG;DING-SHINN CHEN;JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:12:48Z |
Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma
|
Lin, C.-L.;Chen, J.-D.;Liu, C.-J.;Lee, P.-H.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Lin, CL; PO-HUANG LEE; CHUN-JEN LIU; Chen, JD; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lee, PH; Chen, PJ; Lai, MY; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T04:57:10Z |
Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma
|
Ni, YH;Chang, MH;Wang, KJ;Hsu, HY;Chen, HL;Kao, JH;Yeh, SH;Jeng, YM;Tsai, KS;Chen, DS.; Ni, Y.-H., Chang, M.-H., Wang, K.-J., Hsu, H.-Y., Chen, H.-L., Kao, J.-H., Yeh, S.-H., Jeng, Y.-M., Tsai, K.-S., Chen, D.-S.; Ni, YH; HONG-YUAN HSU; KEH-SUNG TSAI; Chang, MH; Wang, KJ; MEI-HWEI CHANG; YUNG-MING JENG; Hsu, HY; Chen, HL; DING-SHINN CHEN; Kao, JH; Yen-Hsuan Ni; JIA-HORNG KAO; Yeh, SH; Jeng, YM; SHIOU-HWEI YEH; Tsai, KS; Chen, DS. |
| 國家衛生研究院 |
2017-08 |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu, YC;Mo, LR;Chang, CY;Wu, MS;Yang, TH;Kao, JH;Chen, CC;Tseng, CH;Tai, CM;Lin, CW;Wu, CY;Lin, JT |
| 國家衛生研究院 |
2016-12-20 |
Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, WL;Yang, HC;Hsu, CS;Wang, CC;Wang, TS;Kao, JH;Chen, DS |
| 國家衛生研究院 |
2015-01 |
Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant mu-opioid receptor gene in spinal cord
|
Kao, JH;Gao, MJ;Yang, PP;Law, PY;Loh, HH;Tao, PL |
| 國立交通大學 |
2014-12-08T15:25:22Z |
A potential-based path planning of articulated robots with 2-DOF joints
|
Chuang, JH; Lin, CC; Kao, JH; Hsieh, CT |
| 國立交通大學 |
2014-12-08T15:18:51Z |
Identity verification by relative 3-D structure using multiple facial images
|
Kao, JH; Chen, YH; Chuang, JH |
| 國立交通大學 |
2014-12-08T15:17:39Z |
Automatic chromosome classification using medial axis approximation and band profile similarity
|
Kao, JH; Chuang, JH; Wang, TP |
| 國立交通大學 |
2014-12-08T15:01:49Z |
Ultrathin N2O-oxide with atomically flat interfaces
|
Chin, A; Chen, WJ; Lin, BC; Kao, JH; Tsai, C; Huang, JCM |
| 中國醫藥大學 |
2014-11 |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|
(Manns M)*;(Pol S);(Jacobson IM);(Marcellin P);(Gordon SC);彭成元(Cheng-Yuan Peng);(Chang TT);(Everson GT);(Heo J);(Gerken G);(Yoffe B);(Towner WJ);(Bourliere M);(Metivier S);(Chu CJ);(Sievert W);(Bronowicki JP);(Thabut D);(Lee YJ);(Kao JH);(McPhee F);(Kopit J);(Mendez P);(Linaberry M);(Hughes E);(Noviello S) |
| 國家衛生研究院 |
2014-06 |
Treatment of skin cancer pain with naltrexone in mice locally transfected with a mutant mu-opioid receptor gene in spinal cord
|
Tao, PL;Kung, WH;Kao, JH;Yang, PP;Law, PY;Loh, HH |
| 中國醫藥大學 |
2014-01 |
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-na?ve Taiwanese patients with chronic hepatitis B
|
(Chien RN);彭成元(Cheng-Yuan Peng);(Kao JH);(Hu TH);(Lin CC);(Hu CT);(Chen CY);(Hsieh TY);(Lin HC);(Chuang WL)* |
| 臺北醫學大學 |
2014 |
Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new onset diabetes: A nationwide cohort study
|
Huang, YW;Yang, SS;Fu, SC;Wang, TC;Hsu, CK;Chen, DS;Hu, JT;Kao, JH |
| 臺北醫學大學 |
2014 |
Reduced Toll-like receptor-9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
Huang, YW;Hsu, CK;Lin, SC;Wei, SC;Hu, JT;Chang, HY;Liang, CW;Chen, DS;Chen, PJ;Hsu, PN;Yang, SS;Kao, JH |
| 臺北醫學大學 |
2014 |
On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogues therapy
|
Huang, YW;Takahashi, S;Tsuge, M;Chen, CL;Wang, TC;Abe, H;Hu, JT;Chen, DS;Yang, SS;Chayama, K;Kao, JH |
| 臺北醫學大學 |
2014 |
Detectability and clinical significance of serum hepatitis B virus ribonucleic acid
|
Huang, YW;Chayama, K;Kao, JH;Yang, SS |
| 臺北醫學大學 |
2014 |
Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients
|
Huang, YW;Yang, SS;Kao, JH |
| 中國醫藥大學 |
2013-03 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced HBeAg seroconversion
|
(Yang HC);(Chen CL);(Shen YC);彭成元(Cheng-Yuan Peng);(Liu CJ);(Tseng TC);(Su TH);(Chuang WL);(Yu ML);(Dai CY);(Liu CH);(Chen PJ);(Chen DS);(Kao JH)* |
| 中國醫藥大學 |
2013-01 |
Viral load and ALT correlate with serologic response in chronic hepatitis B patients treated with entecavir
|
(Wang CC);(Tseng KC);彭成元(Cheng-Yuan Peng);(Hsieh TY);(Lin CL);(Su TH);(Tseng TC);(Hsu CS);(Lin HH);(Kao JH)* |
Showing items 1-50 of 161 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
|
